Interim 3′-deoxy-3′-[18F]fluorothymidine (iFLT) PET/CT was superior to interim 18F-fluorodeoxyglucose (iFDG) PET/CT in predicting outcomes of patients with DLBCL treated with R-CHOP or R-EPOCH, a study found. iFLT-PET/CT had a higher rate of negative results, compared to iFDG-PET/CT by Deauville criteria, and a lower rate of positive results.

Read more.

https://link.springer.com/article/10.1007/s00259-021-05353-9